Stockreport

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

Vivos Therapeutics, Inc.  (VVOS) 
PDF LITTLETON, Colo., April 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare servic [Read more]